The technology and healthcare integration is accelerating fast and female founders are spearheading this evolution. Women are making advances in diagnostics, AI, reproductive health, maternal care and medtech.
A lot of work has been done, attracting venture capital and altering the digital health landscape. Women founders are strengthening the health tech sector and challenging the current state of women’s health as a niche healthcare concern.
Femtech is A $60 Billion Sector and Growing
The femtech industry reached an estimated value of $60 billion in 2024 and is projected to reach $103 billion by 2030. The increasing valuation of this market indicates the interest and demand for tech-enabled health solutions within this space. These solutions are being developed by founders with a solid understanding of the challenges and opportunities within the field.
In October 2025, prominent women’s health investor Jessica Federer scaled up institutional support for the sector as managing director of The Women’s Health Fund, helping oversee the launch of WH1, a flagship fund-of-funds designed to activate major life sciences capital.
The AI Governance Moment and Who Is Shaping It
A 2026 benchmark study found that no large language model exceeded 75% accuracy on women’s health clinical scenarios.The same study found that models consistently failed most on what researchers called ‘missed urgency’, the moments when a woman’s situation was most dangerous and the AI’s response was least reliable.
This performance gap became the immediate catalyst for the Women’s Health AI Consortium’s establishment in May 2026, with female founders taking the lead in constructing the industry’s response before government regulators moved to mandate one.
More from Guides
- Here’s How VoIP Can Give Your Marketing A Real Edge
- What Does A Hedge Fund Manager Do?
- What Is Multi-Modal AI?
- How to Validate a Pet Food Business Idea Before Launch
- What Makes A “Good Call”? AI Call Scoring Breaks It Down
- What Is A Lean Startup?
- How Do I Convert My Home Phone To VoIP?
- What Is The AARRR Framework For Startups?
Sarah O’Leary-Willow
As the CEO of Willow, which focuses on connected maternal health services and advanced breast pump technology, Sarah O’Leary has become an industry luminary in the intersection of healthcare, AI governance and product innovation. In May 2026, O’Leary co-founded the Women’s Health AI Consortium alongside Ema EQ, in an effort to initiate the first industry-wide benchmarks for assessment of clinical safety, AI bias and transparency in Women’s Health.
Amanda Ducac-Ema EQ
Amanda Ducach, co-founder of the Consortium with Willow and CEO of Ema EQ, has built one of the most capital-efficient AI platforms in the space. She secured $3 million in funding to create a proprietary hybrid language model integrated with clinical governance, bias monitoring and AI. Building something scalable with that funding, The Ema EQ case has become one of the most cited examples in the conversation about capital efficiency among female-founded technology companies.
Ridhi Tariyal-NextGen Jane
Ridhi Tariyal is the founder of NextGen Jane, a women’s health company developing a non-invasive test for the diagnosis of endometriosis, a disease that affects the health of women in the tens of millions. Because the current method of diagnosis is surgery, it is a pressing need. Having received a $2.2 million NIH grant in 2025, Tariyal’s work sits at the frontier of diagnostic innovation, applying molecular biology to a clinical problem that has remained largely unsolved for decades.
Iman Abuzeid-Incredible Health
As the CEO and co-founder of Incredible Health, Iman Abuzeid is the leader of an AI-powered career marketplace that helps hospitals recruit permanent healthcare professionals rather than relying on temporary staffing. The solution has been adopted by over 1,500 hospitals and healthcare organisations as well as over 1 million healthcare professionals across the United States. Abuzeid has successfully created a two-sided marketplace at a significant scale that addresses one of the most challenging operational gaps in the delivery of health services, while also creating a new category within enterprise health technology.
Dr Ariella Heffernan-Marks-Ovum
Dr Ariella Heffernan-Marks is the founder of Ovum, an Australian FemTech company aiming to create the first ever AI, longitudinal dataset on women’s health in Australia. The platform will have the capacity to collect and store a diverse range of women’s health records, including blood work, imaging and other medical data.
Anna Jeter-AOA Dx
Anna Jeter is co-founder of AOA Dx and lead author of the Follow the Exits report, which documented the true scale of women’s health exit activity. When you look up these companies in PitchBook, they’re all segmented under equipment or diagnostics. None of them are classified as women’s health,”Jeter noted, identifying a structural problem in investment database taxonomy that has materially affected capital allocation. AOA Dx is simultaneously building a diagnostic business and reshaping how the investment community understands and tracks the sector.
